Caplacizumab Biosimilar – Anti-VWF A1 domain mAb – Research Grade

Reference:
Size

,

Isotype

VH-VH

Brand

Product type

Clonality

Expression system

Applications

,

Product nameCaplacizumab Biosimilar - Anti-VWF A1 domain mAb - Research Grade
SourceCAS 915810-67-2
SpeciesHumanized
Expression systemMammalian cells
Molecular weight28kDa
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsCaplacizumab,ALX-0081,PMP12A2h1-linker AAA-PMP12A2h1,caplacizumab-yhdp,VWF A1 domain,anti-VWF A1 domain
ReferencePX-TA1278
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeVH-VH
ClonalityMonoclonal Antibody

Description of Caplacizumab Biosimilar - Anti-VWF A1 domain mAb - Research Grade

General information on Anti-VWF A1 domain[Homo sapiens] (Caplacizumab) Monoclonal Antibody

Caplacizumab is a humanized single-variable-domain immunoglobulin. Caplacizumab is used in the treatment of Thrombotic Thrombocytopenic Purpura (aTTP). It is marketed under the trade name Cablivi.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Caplacizumab Biosimilar – Anti-VWF A1 domain mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products